- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Procedural Changes With Chemotherapy Dispensing Under OCM
OCM provides focus on individual patient cases. Learn how OCM affects the interaction between healthcare professional and patient.
OCM provides focus on individual patient cases. Learn how OCM affects the interaction between healthcare professional and patient.
Rebecca McCormack, CPhT, patient assistant coordinator at Carolina Blood and Cancer Care Associates
Here at Carolina Blood and Cancer I handle all the infusion mixing for the chemotherapy infusions, the iron infusions, and we also do some Remicade infusions for patients who need that, as well as coordinating ordering supplies and medications for both locations. And I also handle the patient assistance side, the foundation help for all the patients, and the oral dispensing pharmacy at both locations.
Under the Oncology Care Model, you are more apt to be more in contact with each patient that you’re dispensing stuff for. It allows me to get to learn about each patient’s case more than I would have in the past. Honestly, not too much changed from the way I was doing it before in my role, specifically. But it has interaction with the patient a lot more.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
